Vistal, Charles G.

HRN: 05-45-43  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/11/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/11/2026
08/18/2026
IV
4.5g
Q6
ARF; HIE Sec To CAP MR With Aspiration Component
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines